Praiseldy Langi Sasongko

147 Mapping opportunities and threats for the future demand of red blood cells in the Netherlands Table 4.1 Characteristics of experts (Continued) Characteristics All experts (n, % of total), total = 55 Step 2 experts (n, % of total), total = 19 Step 3 experts (n, % of total), total = 14 International 15 (27%) 3 (16%) 1 (7%) Functions Management only 8 (15%) 4 (21%) 2 (14%) Researcher-management 15 (27%) 5 (26%) 5 (36%) Researcher 2 (4%) 2 (11%) 2 (14%) Clinician/clinical-background-researcher 10 (18%) 6 (32%) 2 (14%) Clinician-researcher-management 18 (33%) 2 (11%) 2 (14%) Other 2 (4%) — 1 (7%) aThis included 2 retired Sanquin employees and 1 retired Dutch clinician/clinical-background. II. Scenario development sessions and survey Description of the themes A description of each theme is found in Table 4.2. Table 4.2 Description of the 10 themes Theme Description Sanquin’s blood supply organization This theme concerns internal opportunities and threats regarding the blood bank’s leadership (strengths/weaknesses), national collaborations (e.g., with hospital and academic centers, commercial companies or charitable organizations), internal processes (e.g., supply chain), innovation aspects, and research. RBC replacements This includes opportunities and threats related to alternatives to RBCs (e.g., cultured RBCs, cellular products/therapies) and changes in demand of RBCs (e.g., decrease due to effects of alternative products/therapies or improved population health). Precision medicine This includes opportunities and/or threats related to personalized blood management (e.g., personalized donation or transfusion trigger) and on specialized patients who need specialized products. Commercialization/ open EU market This regards opportunities and/or threats related to blood products in an open market, open borders, and related costs and methods for commercialization. Change in perceptions This theme refers to opportunities and/or threats related to positive donor perception (and methods of creating this), negative donor perception, and other stakeholders’ (e.g., general public, hospitals, Sanquin employees) perception towards Sanquin.

RkJQdWJsaXNoZXIy MTk4NDMw